Afya (AFYA) Expected to Announce Quarterly Earnings on Wednesday

Afya (NASDAQ:AFYA) is anticipated to issue its Q3 2025 results before the market opens on Wednesday, November 12th. Analysts expect the company to announce earnings of $0.32 per share and revenue of $170.9590 million for the quarter. Parties may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Wednesday, November 12, 2025 at 5:00 PM ET.

Afya Price Performance

Shares of AFYA stock opened at $14.13 on Wednesday. Afya has a 1-year low of $13.47 and a 1-year high of $19.90. The stock’s 50-day moving average is $15.17 and its 200 day moving average is $16.37. The company has a market cap of $1.32 billion, a P/E ratio of 10.70, a PEG ratio of 0.43 and a beta of 0.57. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.94 and a quick ratio of 0.94.

Analyst Ratings Changes

AFYA has been the topic of a number of recent research reports. Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 18th. UBS Group upgraded Afya from a “neutral” rating to a “buy” rating and decreased their price target for the company from $19.50 to $19.00 in a research note on Monday, September 8th. Citigroup upgraded Afya from a “sell” rating to a “neutral” rating and decreased their price target for the company from $16.00 to $14.00 in a research note on Tuesday, July 29th. Zacks Research upgraded Afya to a “hold” rating in a research note on Friday, August 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Afya currently has a consensus rating of “Hold” and an average target price of $18.20.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Jump Financial LLC purchased a new position in Afya during the second quarter valued at approximately $731,000. Goldman Sachs Group Inc. raised its position in Afya by 167.3% during the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after acquiring an additional 28,226 shares in the last quarter. Geode Capital Management LLC raised its position in Afya by 85.1% during the second quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock valued at $931,000 after acquiring an additional 23,961 shares in the last quarter. Engineers Gate Manager LP purchased a new position in Afya during the second quarter valued at approximately $363,000. Finally, PDT Partners LLC raised its position in Afya by 50.7% during the second quarter. PDT Partners LLC now owns 51,439 shares of the company’s stock valued at $919,000 after acquiring an additional 17,307 shares in the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.